lobbying_activities: 2469546

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2469546	b7daf880-bcf4-42b0-b420-31a8d2d6e3cf	Q2	BLUECROSS BLUESHIELD OF TENNESSEE	6440	BLUECROSS BLUESHIELD OF TENNESSEE	2020	second_quarter	PHA	Opioid and prescription drug pricing issues; Rx drug rebates; regulation of pharmacy benefit managers; CREATES Act;. H.R.3 - 116th Congress (2019-2020) Lower Drug Costs Now Act of 2019	HOUSE OF REPRESENTATIVES,SENATE		25000	0	0	2020-07-16T16:19:12.743000-04:00